Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 3,092 shares at $61.81 ($193K) on 2017-11-01, disclosed to the SEC on 2017-11-03.
Seasonal sale ($193k) by Chief Scientific Officer — this insider has traded AGIO in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.81 | 946 | $58K | 30.3% |
| 2 | $61.81 | 946 | $58K | 30.3% |
| 3 | $63.09 | 900 | $57K | 29.4% |
| 4 | $63.62 | 200 | $13K | 6.6% |
| 5 | $65.45 | 100 | $7K | 3.4% |
| Total | $62.42 avg | 3,092 |
| $193K |
| 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |